ASX · —
Arovella Therapeutics Limited (ALA.AX) Stock
$0.05
+0.00%
ASX: ALA.AX
—
—
Valuation
Financials & Margins
Latest News
Oracle Makes Fresh AI Push Into Healthcare
GuruFocus.com · Aug 19, 2026
Nebius Stock Tumbles 10% After Taking $4.5 Billion in Debt
GuruFocus.com · Aug 19, 2026
Wedbush Flags Surprising Move in Intel GPU Prices
GuruFocus.com · Aug 19, 2026
Bernie Sanders pushes to end Social Security garnishments for student debt: What to know
Yahoo Personal Finance · Aug 19, 2026
Schwab Targets 2,000 India Staff While Peers Restructure
GuruFocus.com · Aug 19, 2026
Valuation & Return Ratios
Ownership
Insiders Held23.83%
Institutions Held12.06%
Institutions Float Held15.84%
Peer Comparison
About Arovella Therapeutics Limited
—
Arovella Therapeutics Limited (ALA.AX) stock trades at $0.05 with a market capitalization of $73.74M. The stock is valued at a price-to-earnings (P/E) ratio of -7.00, price-to-book of 5.08, price-to-sales of 21.08. Over the past 52 weeks the stock has ranged between $0.05 and $0.11, and currently trades 54.5% below its 52-week high.
On profitability, Arovella Therapeutics Limited generates a return on equity (ROE) of -40.41%, an operating margin of -71.50%, a net profit margin of -197.72%.
Official website: www.arovella.com